224 related articles for article (PubMed ID: 33779731)
1. RNA-Seq analysis reveals critical transcriptome changes caused by sodium butyrate in DN mouse models.
Yang H; Zhang Z; Peng R; Zhang L; Liu H; Wang X; Tian Y; Sun Y
Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33779731
[TBL] [Abstract][Full Text] [Related]
2. Whole transcriptome analysis of diabetic nephropathy in the db/db mouse model of type 2 diabetes.
Wen L; Zhang Z; Peng R; Zhang L; Liu H; Peng H; Sun Y
J Cell Biochem; 2019 Oct; 120(10):17520-17533. PubMed ID: 31106482
[TBL] [Abstract][Full Text] [Related]
3. Whole transcriptome mapping reveals the lncRNA regulatory network of TFP5 treatment in diabetic nephropathy.
Luo H; Yang L; Zhang G; Bao X; Ma D; Li B; Cao L; Cao S; Liu S; Bao L; E J; Zheng Y
Genes Genomics; 2024 May; 46(5):621-635. PubMed ID: 38536617
[TBL] [Abstract][Full Text] [Related]
4. Microarray analysis reveals long non‑coding RNA SOX2OT as a novel candidate regulator in diabetic nephropathy.
Zhang X; Shang J; Wang X; Cheng G; Jiang Y; Liu D; Xiao J; Zhao Z
Mol Med Rep; 2018 Dec; 18(6):5058-5068. PubMed ID: 30320339
[TBL] [Abstract][Full Text] [Related]
5. An integrated RNA sequencing and network pharmacology approach reveals the molecular mechanism of dapagliflozin in the treatment of diabetic nephropathy.
Bai Z; Xie T; Liu T; Chen Z; Yu L; Zhang C; Luo J; Chen L; Zhao X; Xiao Y
Front Endocrinol (Lausanne); 2022; 13():967822. PubMed ID: 36213291
[TBL] [Abstract][Full Text] [Related]
6. Transcriptome expression profiles associated with diabetic nephropathy development.
Jing J; Song L; Zuo D; Li W; Sun Y; Ma X; Ren J
Mol Cell Biochem; 2022 Jul; 477(7):1931-1946. PubMed ID: 35357607
[TBL] [Abstract][Full Text] [Related]
7. The topological key lncRNA H2k2 from the ceRNA network promotes mesangial cell proliferation in diabetic nephropathy
Chen W; Peng R; Sun Y; Liu H; Zhang L; Peng H; Zhang Z
FASEB J; 2019 Oct; 33(10):11492-11506. PubMed ID: 31336052
[TBL] [Abstract][Full Text] [Related]
8. Microarray analysis of long noncoding RNA expression patterns in diabetic nephropathy.
Chen S; Dong C; Qian X; Huang S; Feng Y; Ye X; Miao H; You Q; Lu Y; Ding D
J Diabetes Complications; 2017 Mar; 31(3):569-576. PubMed ID: 28007334
[TBL] [Abstract][Full Text] [Related]
9. LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy.
Yi H; Peng R; Zhang LY; Sun Y; Peng HM; Liu HD; Yu LJ; Li AL; Zhang YJ; Jiang WH; Zhang Z
Cell Death Dis; 2017 Feb; 8(2):e2583. PubMed ID: 28151474
[TBL] [Abstract][Full Text] [Related]
10. Altered Expression of Long Noncoding and Messenger RNAs in Diabetic Nephropathy following Treatment with Rosiglitazone.
Zhang L; Zhou Y; Zhou F; Yu X; Liu J; Liu Y; Zhu Y; Wang W; Chen N
Biomed Res Int; 2020; 2020():1360843. PubMed ID: 32025515
[TBL] [Abstract][Full Text] [Related]
11. Identification of urinary extracellular vesicles differentially expressed RNAs in diabetic nephropathy via whole-transcriptome integrated analysis.
Zhao Z; Yan Q; Fang L; Li G; Liu Y; Li J; Pan S; Zhou S; Duan J; Liu D; Liu Z
Comput Biol Med; 2023 Nov; 166():107480. PubMed ID: 37738894
[TBL] [Abstract][Full Text] [Related]
12. An integrated network pharmacology and transcriptomic method to explore the mechanism of the total Rhizoma Coptidis alkaloids in improving diabetic nephropathy.
Xiao Y; Liu Y; Lai Z; Huang J; Li C; Zhang Y; Gong X; Deng J; Ye X; Li X
J Ethnopharmacol; 2021 Apr; 270():113806. PubMed ID: 33444721
[TBL] [Abstract][Full Text] [Related]
13. Transcriptome analysis identified a novel 3-LncRNA regulatory network of transthyretin attenuating glucose induced hRECs dysfunction in diabetic retinopathy.
Shao J; Zhang Y; Fan G; Xin Y; Yao Y
BMC Med Genomics; 2019 Oct; 12(1):134. PubMed ID: 31615521
[TBL] [Abstract][Full Text] [Related]
14. Identification of novel targets of diabetic nephropathy and PEDF peptide treatment using RNA-seq.
Rubin A; Salzberg AC; Imamura Y; Grivitishvilli A; Tombran-Tink J
BMC Genomics; 2016 Nov; 17(1):936. PubMed ID: 27855634
[TBL] [Abstract][Full Text] [Related]
15. Long non-coding RNA ENSMUST00000147869 protects mesangial cells from proliferation and fibrosis induced by diabetic nephropathy.
Wang M; Yao D; Wang S; Yan Q; Lu W
Endocrine; 2016 Oct; 54(1):81-92. PubMed ID: 27083175
[TBL] [Abstract][Full Text] [Related]
16. Identification of key lncRNAs contributing to diabetic nephropathy by gene co-expression network analysis.
Shang J; Wang S; Jiang Y; Duan Y; Cheng G; Liu D; Xiao J; Zhao Z
Sci Rep; 2019 Mar; 9(1):3328. PubMed ID: 30824724
[TBL] [Abstract][Full Text] [Related]
17. Long non-coding RNA Rpph1 promotes inflammation and proliferation of mesangial cells in diabetic nephropathy via an interaction with Gal-3.
Zhang P; Sun Y; Peng R; Chen W; Fu X; Zhang L; Peng H; Zhang Z
Cell Death Dis; 2019 Jul; 10(7):526. PubMed ID: 31285427
[TBL] [Abstract][Full Text] [Related]
18. Dysregulation of lncRNAs GM5524 and GM15645 involved in high‑glucose‑induced podocyte apoptosis and autophagy in diabetic nephropathy.
Feng Y; Chen S; Xu J; Zhu Q; Ye X; Ding D; Yao W; Lu Y
Mol Med Rep; 2018 Oct; 18(4):3657-3664. PubMed ID: 30132544
[TBL] [Abstract][Full Text] [Related]
19. Sp1-Induced lncRNA Rmrp Promotes Mesangial Cell Proliferation and Fibrosis in Diabetic Nephropathy by Modulating the miR-1a-3p/JunD Pathway.
Yang H; Wang J; Zhang Z; Peng R; Lv D; Liu H; Sun Y
Front Endocrinol (Lausanne); 2021; 12():690784. PubMed ID: 34512545
[TBL] [Abstract][Full Text] [Related]
20. The Long Noncoding RNA 150Rik Promotes Mesangial Cell Proliferation via miR-451/IGF1R/p38 MAPK Signaling in Diabetic Nephropathy.
Zhang Y; Sun Y; Peng R; Liu H; He W; Zhang L; Peng H; Zhang Z
Cell Physiol Biochem; 2018; 51(3):1410-1428. PubMed ID: 30485837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
